| Term 
 
        | Uses of cholinesterase inhibitors |  | Definition 
 
        | Alzheimer's disease (symptom development reduction), reversal of NDMR (an anesthesia), Myasthenia gravis (disease with antibodies against Ach receptors) tx, Central Anticholinergic syndrome (dry as a bone..etc) tx |  | 
        |  | 
        
        | Term 
 
        | Tacrine mode of action? Use? SE? |  | Definition 
 
        | Non-specific cholinesterase inhibitor (AChE and BuChE = butyrylcholine found mostly in liver/periphery), Alzheimer tx. SE: Nausea, vomiting and liver damage (enzymes up) |  | 
        |  | 
        
        | Term 
 
        | Donepezil mode of action and advantage? Use? Halflife? |  | Definition 
 
        | More selective ChEI (for ACh in the CNS) = less BuChE inhibition in periphery and less hepatoxicity. Alzheimer's tx t1/2 = 70 hrs so once a day drug
 |  | 
        |  | 
        
        | Term 
 
        | Rivastigmine mode of action, use? |  | Definition 
 
        | AChE and BuChE inhibitor, Alzheimer's tx |  | 
        |  | 
        
        | Term 
 
        | Tubocurarine mode of action, effect |  | Definition 
 
        | Type of curare (isoquinoline alkaloids) that blocks ACh receptors (nicotinic) at neuromuscular junction, relaxation/paralysis of muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthetic curare, muscle relaxation |  | 
        |  | 
        
        | Term 
 
        | Malouetine, mode of action, effect |  | Definition 
 
        | African aminosteroid that blocks neuromuscular junction, muscle relaxation |  | 
        |  | 
        
        | Term 
 
        | 3 components of anesthesia |  | Definition 
 
        | 1)analgesia like fentanyl 2)sedative like lorazepam 3)NDMR (non-depolarizing muscle relaxant) like pancuronium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | synthetic aminosteriod NDMR (non-depoloarizing muscle relaxant) |  | 
        |  | 
        
        | Term 
 
        | Edrophonium mode of action, effect, advantage, SE?, reversal of its effect? |  | Definition 
 
        | AChE inhibitor w/o CNS penetration, reversal of NDMR, fewer muscarinic effects than neostigmine and distribution terminates after 10 min (low potency); SE: Brochoconstriction, bronchospasm, bradycardia ... Note: don't use atropine to reverse, goes into CNS, use glycopyrrolate (muscarinic blocker w/o BBB penetration) |  | 
        |  | 
        
        | Term 
 
        | Neostigmine, mode of action, effect |  | Definition 
 
        | AChE inhibitor w/o CNS penetration, NDMR reversal (most potent/common) |  | 
        |  | 
        
        | Term 
 
        | Myasthenia gravis drug types? |  | Definition 
 
        | Immunosuppressants, steriods (reduce reactivity of immune system), AChE-Inhibitors...also thymectomy |  | 
        |  | 
        
        | Term 
 
        | Methotrexate mode of action, use, drug interaction |  | Definition 
 
        | immunosuppressant (low dose) = inhibitor of T cell activation and suppression of intercellular adhesion molecule expression, Myasthenia gravis tx; decreased excretion when used along with penicillin like antibiotics (renal tubular competition) |  | 
        |  | 
        
        | Term 
 
        | cyclosporin A mode of action, use |  | Definition 
 
        | immunosuppressant, binds to cyclophilin (immunophilin) of T-lymphocytes. This inhibits calcineurin which normally activates transcription of IL2; myasthenia gravis tx |  | 
        |  | 
        
        | Term 
 
        | Pyridostigmine mode of action, use, SE? |  | Definition 
 
        | AChE inhibitor w/o CNS penetration (more potent/long acting than other AChE inhibitors; first-line tx of Myasthenia gravis, preemptive tx before potential OP/nerve gas exposure; SE: can antagonize muscle relaxants (that block ACh receptors) |  | 
        |  | 
        
        | Term 
 
        | Tacrolimus mode of action, use |  | Definition 
 
        | immunosuppressant (calcineurin inhibitor like cyclosporin), myasthenia gravis tx (gradual reduction of anti-AChR antibodies) |  | 
        |  | 
        
        | Term 
 
        | Organophosphates, toxic effects |  | Definition 
 
        | Pesticides that inhibit AChE; DUMBBELLS (diarrhea, urination, mitosis, bronchorrhea, bronchospasm, emesis, lacrimation, laxation, salivation) |  | 
        |  | 
        
        | Term 
 
        | Treatment of OP (organophosphate poisoning) |  | Definition 
 
        | A FLOP (Atropine [anti-cholinergic], FLuid [atropine makes dry], Oxygen, Pralidoxime [removes OP from Cholinesterase, reactivates] |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Physostigmine mode of action, use |  | Definition 
 
        | Cholinesterase inhibitor that penetrates BBB. Used in ordeal by poison, counters Central Anticholinergeic Syndrome (mad as a hatter, dry as a bone, red as a beet, hot as a hare, blind as a bat). |  | 
        |  | 
        
        | Term 
 
        | Random facts: K effects on digitoxicity, QRS widened in? Verapamil effect on ventricular arrhythmias? insulin inotropic effect? dopamine effect on renal perfusion? |  | Definition 
 
        | hyperkalemia enhances acute, hypokalemia enhances chronic; QRS widened in ventricular arrhthymias, verapamil is counterindicated, slows heart/lowers bp w/o need; insulin most potent inotrope; low dose dopamine increases renal perfusion |  | 
        |  |